Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01808742 · ClinicalTrials.gov registry record
Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the CRYO-TOUCH III Device
A clinical trial of Glabellar Frown Lines and Frown Lines, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- 17
- Enrollment target
- 1
- Study location
NCT01808742 is a study of Glabellar Frown Lines and Frown Lines that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 17 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01808742, a study of Glabellar Frown Lines and Frown Lines, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
myoscience Inc. (Redwood City, CA) has developed a device for a novel, minimally invasive facial rejuvenation procedure designed to soften hyperdynamic facial lines. The myoscience Cryo-Touch III device uses well-established principles of cryobiology to cause localized reduction in muscle activity resulting in a reversible reduction in facial animation and the appearance of facial lines. The device operates on well-established cryobiology principles; that localized exposure to controlled low temperature conditions can alter tissue function. The therapy treats targeted motor nerves with low temperatures via a cold probe in the form of an assembly of small diameter needles, creating a highly localized treatment zone around the probe. The thermal algorithm is designed to produce a reversible loss of nerve conduction resulting in a temporary decrease in muscle contractility. Prior studies of Cryo-Touch, Cryo-Touch II and Cryo-Touch III have provided strong evidence of effectiveness and safety for applications in this indication. The goal of the study described herein is to investigate optimized algorithms and ongoing safety and effectiveness.
Conditions Studied
Interventions
- DEVICE Treatment with CryoTouch III Device
Study Locations (1)
California
- 77 Plastic Surgery - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01808742
The ClinicalTrials.gov registry entry for NCT01808742 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Glabellar Frown Lines appearing as the primary indexed condition, and to 1 intervention - of which Treatment with CryoTouch III Device is the first listed.
NCT01808742 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01808742 about?
NCT01808742 is a clinical study titled "Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the CRYO-TOUCH III Device". myoscience Inc. (Redwood City, CA) has developed a device for a novel, minimally invasive facial rejuvenation procedure designed to soften hyperdynamic facial lines. The myoscience Cryo-Touch III device uses well-established principles of cryobiology to cause localized reduction in muscle activity r...
What is the current status of trial NCT01808742?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2012-11. Estimated completion is 2014-08.
What conditions does trial NCT01808742 study?
This clinical trial studies the following conditions: Glabellar Frown Lines, Frown Lines.
What interventions are being tested in trial NCT01808742?
The interventions under investigation include: Treatment with CryoTouch III Device (DEVICE).
Who is sponsoring clinical trial NCT01808742?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01808742 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glabellar Frown Lines
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.